Parkinson's Disease Clinical Trials in Texas

23 recruiting studies across 6 cities

Browse by City

Austin

All Trials in Texas

Phase

Trial	Phase	Sponsor	Dist.
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease	Phase 1	Prevail Therapeutics	<1 mi
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease	Phase 1	Eli Lilly and Company	<1 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease	—	AbbVie	<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis	Phase 4	VA Office of Research and Development	<1 mi
Parkinson's Foundation PD GENEration Genetic Registry	—	Parkinson's Foundation	<1 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry	—	Boston Scientific Corporation	<1 mi
Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD	N/A	The University of Texas Health Science Center at San Antonio	<1 mi
Comparing Antipsychotic Medications in LBD Over Time	Phase 4	The University of Texas Health Science Center at San Antonio	<1 mi
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease	N/A	The University of Texas Health Science Center at San Antonio	<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease	Phase 2	Neuron23 Inc.	<1 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease	Phase 4	Impax Laboratories, LLC	<1 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications	Phase 3	Cerevance	<1 mi
Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease.	N/A	Nora Vanegas	<1 mi
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)	—	Michael J. Fox Foundation for Parkinson's Research	<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)	Phase 2	AskBio Inc	<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort	—	Michael J. Fox Foundation for Parkinson's Research	<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications	—	InSightec	<1 mi
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease	N/A	University of Texas Southwestern Medical Center	<1 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease	Phase 2	TrueBinding, Inc.	17 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease	Phase 3	Hoffmann-La Roche	17 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease	Phase 2/3	Biohaven Therapeutics Ltd.	17 mi
A Study of Buntanetap in Participants With PD	Phase 2/3	Annovis Bio Inc.	17 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.